Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up - Time to Buy?

Key Points

• Hypermarcas shares opened at $4.35 after closing at $4.01, indicating a gap up before the market opened.
• Scotiabank upgraded Hypermarcas to a "strong-buy" rating, contributing to a consensus rating of "Strong Buy" from analysts.
• The company declared a dividend of $0.0345 per share with an impressive dividend yield of 281.0%, set to be paid on January 8th.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $4.01, but opened at $4.35. Hypermarcas shares last traded at $4.35, with a volume of 789 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Scotiabank raised shares of Hypermarcas to a "strong-buy" rating in a research note on Thursday, July 17th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock has a consensus rating of "Strong Buy".

Hypermarcas Stock Down 5.1%

The company has a market cap of $2.69 billion, a PE ratio of 20.19 and a beta of 0.77. The company's 50 day moving average is $4.60 and its 200 day moving average is $4.09. The company has a current ratio of 1.26, a quick ratio of 0.80 and a debt-to-equity ratio of 0.63.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.12 EPS for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Announces Dividend

The firm also recently announced a dividend, which will be paid on Friday, January 8th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.0345 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a yield of 281.0%. Hypermarcas's dividend payout ratio (DPR) is 57.14%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.